CA23766A
(en)
|
|
1886-04-06 |
Albert M. Todd |
Process of, and appartus for treating essential oils to obtain the concrete or crystalline part thereof separate and apart from the liquid portion
|
CA8748A
(en)
|
|
1878-05-04 |
George W. Ainsworth |
Improvements on clothes dryers
|
CA59350A
(en)
|
1898-02-26 |
1898-03-19 |
Thomas Henry Simmonds |
Brake for velocipede, tricycle, etc.
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US5837249A
(en)
|
1985-04-19 |
1998-11-17 |
The Wistar Institute |
Method for generating an immunogenic T cell response protective against a virus
|
US5726288A
(en)
*
|
1989-11-13 |
1998-03-10 |
Massachusetts Institute Of Technology |
Localization and characterization of the Wilms' tumor gene
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
AU1570292A
(en)
|
1991-02-07 |
1992-09-07 |
Board Of Trustees Of The University Of Illinois, The |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
WO1994021287A1
(en)
|
1993-03-15 |
1994-09-29 |
The Government Of The United States Of America As Represented By The Department Of Health And Human Services |
Peptide coated dendritic cells as immunogens
|
WO1995029240A1
(en)
|
1994-04-22 |
1995-11-02 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
|
US5622835A
(en)
|
1994-04-28 |
1997-04-22 |
The Wistar Institute Of Anatomy & Biology |
WT1 monoclonal antibodies
|
US5643786A
(en)
|
1995-01-27 |
1997-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for isolating dendritic cells
|
US6156316A
(en)
|
1995-05-08 |
2000-12-05 |
Sloan-Kettering Institute For Cancer Research |
Oncogene fusion protein peptide vaccines
|
JPH11171896A
(ja)
|
1995-09-19 |
1999-06-29 |
Kirin Brewery Co Ltd |
新規ペプチド化合物およびその医薬組成物
|
US5981217A
(en)
|
1995-12-11 |
1999-11-09 |
Mayo Foundation For Medical Education And Research |
DNA encoding TGF-β inducible early factor-1 (TIEF-1), a gene expressed by osteoblasts
|
DE69723230T2
(de)
|
1996-01-17 |
2004-05-27 |
Imperial College Innovations Ltd. |
Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl)
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
US6207375B1
(en)
|
1996-12-11 |
2001-03-27 |
Mayo Foundation For Medical Educational & Research |
TGF-β inducible early factor-1 (TIEF-1) and a method to detect breast cancer
|
ID27813A
(id)
|
1998-01-28 |
2001-04-26 |
Corixa Corp |
Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
|
AU4932199A
(en)
|
1998-07-31 |
2000-02-21 |
Haruo Sugiyama |
Cancer antigens based on tumor suppressor gene wt1 product
|
US7144581B2
(en)
|
2000-10-09 |
2006-12-05 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US20030072767A1
(en)
|
1998-09-30 |
2003-04-17 |
Alexander Gaiger |
Compositions and methods for WT1 specific immunotherapy
|
US7655249B2
(en)
|
1998-09-30 |
2010-02-02 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7901693B2
(en)
|
1998-09-30 |
2011-03-08 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7115272B1
(en)
|
1998-09-30 |
2006-10-03 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7329410B1
(en)
|
1998-09-30 |
2008-02-12 |
Corixa Corporation |
Compositions and method for WT1 specific immunotherapy
|
US7063854B1
(en)
*
|
1998-09-30 |
2006-06-20 |
Corixa Corporation |
Composition and methods for WTI specific immunotherapy
|
US20120301492A1
(en)
|
1998-09-30 |
2012-11-29 |
Corixa Corporation |
Compositions and methods for wt1 specific immunotherapy
|
GB9823897D0
(en)
|
1998-11-02 |
1998-12-30 |
Imp College Innovations Ltd |
Immunotherapeutic methods and molecules
|
AU1675900A
(en)
|
1998-12-22 |
2000-07-12 |
Genset |
Complementary dna's encoding proteins with signal peptides
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
AU3755800A
(en)
|
1999-03-15 |
2000-10-04 |
Introgen Therapeutics, Inc. |
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
|
US6593299B1
(en)
*
|
1999-04-21 |
2003-07-15 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for controlling pests
|
WO2001025273A2
(en)
|
1999-10-04 |
2001-04-12 |
Corixa Corporation |
Compositions and methods for wt1 specific immunotherapy
|
US20030082194A1
(en)
|
2000-02-22 |
2003-05-01 |
Alexander Gaiger |
Compositions and methods for diagnosis and therapy of malignant mesothelioma
|
EP1261711A2
(de)
*
|
2000-02-22 |
2002-12-04 |
Corixa Corporation |
Zusammensetzungen und methoden zur diagnose und therapie von malignen mesotheliom
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
EP1209226A3
(de)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Reifen von dendritischen Zellen durch die Verwendung von rekombinante Hitzeschock-Protein 70 (hsp70)
|
US20040097703A1
(en)
|
2001-03-22 |
2004-05-20 |
Haruo Sugiyama |
Wt1 modified peptide
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
CA2451846A1
(en)
|
2001-06-29 |
2003-01-09 |
Chugai Seiyaku Kabushiki Kaisha |
Cancer vaccine comprizing a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome
|
US7553494B2
(en)
|
2001-08-24 |
2009-06-30 |
Corixa Corporation |
WT1 fusion proteins
|
US8735357B2
(en)
|
2001-09-28 |
2014-05-27 |
International Institute Of Cancer Immunology, Inc. |
Method of inducing antigen-specific T cells
|
US20050002951A1
(en)
|
2001-09-28 |
2005-01-06 |
Haruo Sugiyama |
Novel method of inducing antigen-specific t cells
|
US20030072761A1
(en)
|
2001-10-16 |
2003-04-17 |
Lebowitz Jonathan |
Methods and compositions for targeting proteins across the blood brain barrier
|
US20030175272A1
(en)
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
WO2003106682A1
(ja)
|
2002-06-12 |
2003-12-24 |
中外製薬株式会社 |
Hla−a24拘束性癌抗原ペプチド
|
AU2004224425B2
(en)
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
US20050008618A1
(en)
|
2003-02-27 |
2005-01-13 |
Howard Kaufman |
Composition for delivering an agent to a target cell and uses thereof
|
EP1601684B1
(de)
*
|
2003-03-05 |
2014-10-15 |
Dendreon Corporation |
Zusammensetzungen und verfahren unter anwendung von polypeptiden mit alternativem leserahmen zur behandlung von krebs und infektionskrankheiten
|
EP2343083B1
(de)
|
2003-06-27 |
2014-01-15 |
International Institute of Cancer Immunology, Inc. |
Verfahren zum Diagnostizieren von Krebs, umfassend die Messung von WT1-spezifischen CTL-Vorläuferzellen
|
US20050147621A1
(en)
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
US20080070835A1
(en)
|
2003-11-05 |
2008-03-20 |
International Institute Of Cancer Immunology, Inc |
Hla-Dr-Binding Antigen Peptide Derived From Wt1
|
EP1708732B2
(de)
*
|
2003-12-01 |
2016-05-18 |
Sloan-Kettering Institute For Cancer Research |
Synthetische hla bindende peptidanaloge und deren verwendungen
|
ES2484340T3
(es)
|
2003-12-05 |
2014-08-11 |
Multimmune Gmbh |
Anticuerpos anti hsp70 terapéuticos y diagnósticos
|
EP1550458A1
(de)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergisitische liposomale Adjuvantien
|
WO2005087260A1
(en)
|
2004-03-04 |
2005-09-22 |
Corixa Corporation |
Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof
|
US20050214268A1
(en)
|
2004-03-25 |
2005-09-29 |
Cavanagh William A Iii |
Methods for treating tumors and cancerous tissues
|
US20050221481A1
(en)
|
2004-03-30 |
2005-10-06 |
Istituto Superiore Di Sanita' |
Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2
|
DK1731605T3
(da)
|
2004-03-31 |
2010-05-25 |
Int Inst Cancer Immunology Inc |
Cancerantigenpeptider der er afledt af WT1
|
US9629927B2
(en)
|
2005-07-29 |
2017-04-25 |
Sloan-Kettering Institute For Cancer Research |
Single wall nanotube constructs and uses thereof
|
US8765687B2
(en)
|
2005-10-17 |
2014-07-01 |
Sloan Kettering Institute For Cancer Research |
WT1 HLA class II-binding peptides and compositions and methods comprising same
|
JP4394724B2
(ja)
*
|
2005-11-30 |
2010-01-06 |
株式会社癌免疫研究所 |
新規ペプチド化合物
|
CA2886551A1
(en)
|
2006-02-22 |
2007-08-30 |
Haruo Sugiyama |
Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
|
EP2009100B1
(de)
|
2006-03-29 |
2012-07-11 |
International Institute of Cancer Immunology, Inc. |
Für die isoform wt1 17aa(-) spezifische sirna und verwendung davon
|
WO2007120603A2
(en)
|
2006-04-10 |
2007-10-25 |
Sloan Kettering Institute For Cancer Research |
Immunogenic bcr-abl peptides and methods of use thereof
|
CA2645766A1
(en)
|
2006-04-10 |
2007-10-25 |
Sloan Kettering Institute For Cancer Research |
Immunogenic wt-1 peptides and methods of use thereof
|
EP2133365B1
(de)
|
2006-12-27 |
2017-05-17 |
Emory University |
Zusammensetzungen und Verfahren zur Behandlung von Infektionen und Tumoren
|
AU2007340679B2
(en)
|
2006-12-28 |
2013-09-12 |
International Institute Of Cancer Immunology, Inc. |
HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
|
EP2127671B1
(de)
|
2007-02-07 |
2016-09-14 |
Nec Corporation |
Therapeutisches krebsmittel
|
PT2119778E
(pt)
|
2007-02-27 |
2016-02-15 |
Int Inst Cancer Immunology Inc |
Método para ativação de célula t auxiliar e composição para utilização no método
|
TW200911304A
(en)
|
2007-05-24 |
2009-03-16 |
Glaxosmithkline Biolog Sa |
Lyophillised antigen composition
|
KR100995340B1
(ko)
|
2007-11-19 |
2010-11-19 |
재단법인서울대학교산학협력재단 |
자연 살해 t 세포의 리간드와 항원을 적재한 단핵구 또는미분화 골수성 세포를 포함하는 백신
|
CA2881594C
(en)
|
2007-12-05 |
2016-04-12 |
International Institute Of Cancer Immunology, Inc. |
Cancer vaccine composition
|
KR100900837B1
(ko)
|
2007-12-07 |
2009-06-04 |
(주)두비엘 |
리포펩타이드와 폴리(i:c)를 아쥬반트로 포함하는 강력한백신 조성물
|
AU2009249273A1
(en)
|
2008-05-19 |
2009-11-26 |
Aduro Biotech |
Compositions comprising PrfA*mutant listeria and methods of use thereof
|
US20110318380A1
(en)
*
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
AR076349A1
(es)
|
2009-04-23 |
2011-06-01 |
Int Inst Cancer Immunology Inc |
Peptido auxiliar del antigeno del cancer
|
WO2011059835A2
(en)
|
2009-11-11 |
2011-05-19 |
Quest Diagnostics Investments Incorporated |
Wt1 mutations for prognosis of myeloproliferative disorders
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
JP2013536240A
(ja)
|
2010-08-24 |
2013-09-19 |
ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション |
インターロイキン−13受容体α2ペプチド脳がんワクチン
|
AR083295A1
(es)
|
2010-10-05 |
2013-02-13 |
Univ Osaka |
Metodo para activar celulas t auxiliares
|
KR20140022836A
(ko)
|
2011-03-11 |
2014-02-25 |
길리아드 칼리스토가 엘엘씨 |
혈액 악성종양에 대한 조합 요법
|
CN105968191A
(zh)
|
2011-06-28 |
2016-09-28 |
株式会社癌免疫研究所 |
肽癌抗原-特异性t细胞的受体基因
|
EP2738253A4
(de)
|
2011-07-29 |
2015-04-22 |
Riken |
Zelle zur verwendung in der immuntherapie mit für wilms-tumorgenprodukt oder fragment davon codierendem modifiziertem nukleinsäurekonstrukt, verfahren zur herstellung dieser zelle und besagtes nukleinsäurekonstrukt
|
US9539299B2
(en)
|
2011-10-27 |
2017-01-10 |
International Institute Of Cancer Immunology, Inc. |
Combination therapy with WT1 peptide vaccine and temozolomide
|
JP6218175B2
(ja)
|
2011-12-14 |
2017-10-25 |
国立大学法人高知大学 |
ヘルパーt細胞誘導性ポリペプチドの改変
|
EP3520810A3
(de)
|
2012-01-13 |
2019-11-06 |
Memorial Sloan-Kettering Cancer Center |
Immunogene wt-1-peptide und verwendung davon
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
NZ702108A
(en)
|
2012-05-03 |
2016-09-30 |
Hutchinson Fred Cancer Res |
Enhanced affinity t cell receptors and methods for making the same
|
WO2014007266A1
(ja)
|
2012-07-02 |
2014-01-09 |
大日本住友製薬株式会社 |
癌抗原ペプチド経皮剤
|
CN105007930B
(zh)
|
2012-10-23 |
2018-08-17 |
优比维克有限责任公司 |
用于治疗疾病的同种异体自噬体富集组合物
|
WO2014098012A1
(ja)
|
2012-12-17 |
2014-06-26 |
大塚製薬株式会社 |
ヘルパーt細胞の活性化方法
|
EP2940134A4
(de)
|
2012-12-26 |
2016-08-10 |
Biocomo Inc |
Mithilfe des menschlichen parainfluenzavirus-typ- 2-vektors hergestellter impfstoff
|
US9919037B2
(en)
|
2013-01-15 |
2018-03-20 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
EP2762152A1
(de)
|
2013-02-05 |
2014-08-06 |
Nitto Denko Corporation |
WT1-Peptidkrebsimpfstoffzusammensetzung zur transdermalen Verabreichung
|
US10195258B2
(en)
|
2013-02-05 |
2019-02-05 |
Nitto Denko Corporation |
Tape preparation of WT1 peptide cancer vaccine for transdermal administration
|
RU2687144C2
(ru)
|
2013-02-05 |
2019-05-07 |
Нитто Денко Корпорейшн |
Композиция противораковой вакцины, содержащей пептид wt1, для трансдермального введения
|
CN103961702B
(zh)
|
2013-02-05 |
2019-04-09 |
日东电工株式会社 |
粘膜给予用wt1肽癌症疫苗组合物
|
WO2014127296A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd |
Cancer vaccines and vaccination methods
|
ES2694328T3
(es)
|
2013-03-12 |
2018-12-19 |
Sumitomo Dainippon Pharma Co., Ltd. |
Composición acuosa líquida
|
EP3607974A1
(de)
|
2013-03-15 |
2020-02-12 |
The Trustees of The University of Pennsylvania |
Krebsimpfstoffe und verfahren zur behandlung unter verwendung davon
|
MY171854A
(en)
|
2013-03-29 |
2019-11-05 |
Sumitomo Dainippon Pharma Co Ltd |
Wt1 antigen peptide conjugate vaccine
|
CA2910213A1
(en)
|
2013-04-25 |
2014-10-30 |
Vaximm Ag |
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene wt1
|
CN111781359A
(zh)
|
2013-05-13 |
2020-10-16 |
株式会社癌免疫研究所 |
用于预测免疫疗法的临床效果的方法
|
WO2015002134A1
(ja)
|
2013-07-02 |
2015-01-08 |
公益財団法人がん研究会 |
細胞性免疫誘導ワクチン
|
WO2015077607A1
(en)
|
2013-11-22 |
2015-05-28 |
The Board Of Trustees Of The University Of Illinois |
Engineered high-affinity human t cell receptors
|
HUE045567T2
(hu)
|
2013-12-18 |
2020-01-28 |
Vaximm Gmbh |
MSLN-t célzó DNS vakcina rák immunterápiához
|
WO2015103602A1
(en)
|
2014-01-06 |
2015-07-09 |
The Trustees Of The University Of Pennsylvania |
Pd1 and pdl1 antibodies and vaccine combinations and use of same for immunotherapy
|
SG11201606625RA
(en)
|
2014-02-14 |
2016-09-29 |
Immune Design Corp |
Immunotherapy of cancer through combination of local and systemic immune stimulation
|
EP3112378B1
(de)
|
2014-02-26 |
2020-06-24 |
Tella, Inc. |
Wt1-antigenes polypeptid und antitumormittel mit besagtem polypeptid
|
US10023841B2
(en)
|
2014-05-23 |
2018-07-17 |
Baylor Research Institute |
Methods and compositions for treating breast cancer with dendritic cell vaccines
|
EP3231438B1
(de)
|
2014-12-11 |
2020-06-17 |
International Institute of Cancer Immunology, Inc. |
Wt1 immuntherapie für intraokulare angiogene erkrankungen
|
CN108350411B
(zh)
|
2015-06-25 |
2021-06-22 |
白川利朗 |
口服肿瘤疫苗
|
WO2017049074A1
(en)
|
2015-09-18 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotide formulations for use in the treatment of renal diseases
|